Ola Tech 100mg - Olaparib Tablets

Get a Price/Quote

MOQ : 1 Bottle

Ola Tech 100mg - Olaparib Tablets Specification

Dosage Form
Tablets

Origin
India

Salt Composition
Olaparib Tablets

Indication
Treatment of ovarian, breast, pancreatic, and prostate cancers with BRCA mutations; maintenance therapy in certain cancers

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
N/A

Temperature Needed For Fermentation
25 Celsius (oC)

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Enzymatic Activity
PARP (Poly ADP-Ribose Polymerase) Inhibitor; blocks DNA repair in cancer cells

Storage Instructions
Store below 25 30 C in a cool, dry place; protect from moisture and light

Shelf Life
24 Months

Ola Tech 100mg - Olaparib Tablets Trade Information

Minimum Order Quantity
1 Bottle

FOB Port
Delhi

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Bottles Per Month

Delivery Time
5 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
Box

Main Export Market(s)
Asia

Main Domestic Market
All India

Certifications
N/A

Ola Tech 100mg - Olaparib Tablets About

Background and Date of approval OLAPARIB

Olaparib is an anticancer medicine referred to as the Poly Adenosine Diphosphate-Ribose Polymerase (PARP) inhibitor. It was approved for its medical use on 19th December 2014.

Uses of OLAPARIB

Olaparib Tablet has been developed as a maintenance therapy to treat adult patients with cancer in the ovaries, fallopian tube, peritoneum, pancreas, prostate due to BRCA mutation and have completely or partially responded to platinum-based chemotherapy.

How is OLAPARIB administered?

The recommended dose of Olaparib Tablet is 300mg twice a day with or without food. Olaparib Tablet is available in the doses of 100mg and 150mg and the strength varies according to the patients health condition. In patients with kidney impairment, the recommended dose is 200mg twice a day.

Side Effects of OLAPARIB

The common side effects that are likely to occur while you are on the treatment with Olaparib Tablet are nausea, vomiting, stomach ache, diarrhea, breathing difficulty, constipation, tiredness, indigestion, upper respiratory tract infection, urinary tract infection, dizziness, low levels of RBC, WBC and platelets in blood, and decreased appetite. If you experience unusual bleeding, bruising, rapid heartbeat, or swelling of the face and eyes, report to your doctor immediately.